Concepts and misconceptions regarding clinical staging models

Journal of Psychiatry and Neuroscience

Volumn 41, Issue 6, 2016, Pages E83-E84

  Shah, Jai ^a   Scott, Jan ^b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM;

BIPOLAR DISORDER; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LETTER; PATHOPHYSIOLOGY; PHENOTYPE; PSYCHIATRY; RISK BENEFIT ANALYSIS; RISK FACTOR; STAGING;

EID: 84992494217     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.160196     Document Type: Letter

References (16)

1. Alda M, Kapczinski F. Staging model raises fundamental questions about the nature of bipolar disorder. J Psychiatry Neurosci 2016;41:291-3.
2. Scott J, Leboyer M, Hickie I, et al. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry 2013;202: 243-5.
3. Kim-Cohen J, Caspi A, Moffitt TE, et al. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry 2003;60:709-17.
4. Shankman SA, Lewinsohn PM, Klein DN, et al. Subthreshold conditions as precursors for full syndrome disorders: a 15-year longitudinal study of multiple ­diagnostic classes. J Child Psychol Psychiatry 2009;50:1485-94.
5. Wright JR. Albert C. Broders’ paradigm shifts involving the prognostication and definition of cancer. Arch Pathol Lab Med 2012;136:1437-46.
6. Gonnella JS, Hornbrook MC, Louis DZ. Staging of disease. A case-mix measurement. JAMA 1984;251:637-44.
7. Bechdolf A, Ratheesh A, Cotton SM, et al. The predictive validity of bipolar atrisk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord 2014;16:493-504.
8. McGorry PD, Hickie IB, Yung AR, et al. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006;40:616-22.
9. Scott J, Hickie IB, McGorry P. Pre-emptive psychiatric treatments: Pipe dream or a realistic outcome of clinical staging models? Neuropsychiatry 2012;2: 263-6.
10. Liu P, Parker AG, Hetrick SE, et al. An evidence map of interventions across premorbid, ultra-high risk and first epi­ sode phases of psychosis. Schizophr Res 2010;123:37-44.
11. Vallarino M, Henry C, Etain B, et al. An evidence map of psychosocial interventions for the earliest stages of bipolar disorder. Lancet Psychiatry 2015;2:548-63.
12. Lønning PE. Breast cancer prognostication and prediction: Are we making progress? Ann Oncol 2007;18(Suppl 8):viii3-7.
13. Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for dia­ betes development. Lancet 2012;379: 2279-90.
14. McGorry P, Keshavan M, Goldstone S, et al. Biomarkers and clinical staging in psychiatry. World Psychiatry 2014;13: 211-23.
15. Bellivier F, Geoffroy PA, Scott J, et al. Biomarkers of bipolar disorder: Specific or shared with schizophrenia? Front Biosci (Elite Ed) 2013;5:845-63.
16. Insel TR. Translating scientific opportunity into public health impact: a stra­ tegic plan for research on mental illness. Arch Gen Psychiatry 2009;66:128-33.